EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficacy of Oral Remdesivir Compared to GS-441524 for Treatment of Cats with Naturally Occurring Effusive Feline Infectious Peritonitis: A Blinded, Non-Inferiority Study

Emma Cosaro, Jully Pires, Diego Castillo, Brian G Murphy iD, Krystle L Reagan iD

Viruses · 2023

DOI: 10.3390/v15081680 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Emma Cosaro und 4 weiteren Autor:innen. Beteiligte Einrichtung: William R. Pritchard Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California, Davis, CA 95616, USA. Hauptthemen laut MEDLINE: Feline Infectious Peritonitis. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Center for Companion Animal Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nucleoside analogs GS-441524 and remdesivir (GS-5734) are effective in treating cats with feline infectious peritonitis (FIP). However, no studies have compared the efficacy between antiviral medications. The objective of this study was to evaluate the efficacy of orally administered GS-442514 (12.5–15 mg/kg) compared to orally administered remdesivir (25–30 mg/kg) in a double-blinded non-inferiority trial. Eighteen cats with effusive FIP were prospectively enrolled and randomly assigned to receive either GS-442514 or remdesivir. Cats were treated daily for 12 weeks and evaluated at week 0, 12, and 16. Survival and disease remission at week 16 were compared between groups. Five of 9 (55%) cats treated GS-441524 and 7/9 (77%) cats treated with remdesivir survived, with no difference in survival rate (p = 0.2). Remdesivir fulfilled the criteria for non-inferiority with a difference in survival of 22% (90% CI; −13.5–57.5%). Three of the 18 cats died within 48 h of enrollment. Excluding these cats, 5/6 (83%) of the cats treated with GS-441524 and 7/9 (77%) of the cats treated with remdesivir survived. These findings suggest that both orally administered GS-441524 and remdesivir are safe and effective anti-viral medications for the treatment of effusive FIP. Further optimization of the first 48 h of treatment is needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Feline Infectious PeritonitisAnimalsCatsAdenosineAntiviral AgentsFuransPyrrolesTriazinesEquivalence Trials as TopicDouble-Blind MethodAdenosine MonophosphateAlanine

Stichwörter der Autor:innen

FIPVantiviralcoronavirusfeline coronavirusnucleoside analogtherapy

Substanzen

AdenosineAntiviral AgentsFuransPyrrolesTriazinesGS-441524remdesivirAdenosine MonophosphateAlanine

Autor:innen und Institutionen

  • William R. Pritchard Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California, Davis, CA 95616, USA.
  • Veterinary Center for Clinical Trials, School of Veterinary Medicine, University of California, Davis, CA 95616, USA.
  • Department of Pathology, Microbiology, and Immunology, School of Veterinary Medicine, University of California, Davis, CA 95616, USA.
  • Department of Veterinary Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, CA 95616, USA.

ORCID-Profile: Brian G Murphy, Krystle L Reagan

Förderung

  • Center for Companion Animal Health

Zitieren

APA

Cosaro, E., Pires, J., Castillo, D., Murphy, B. G., & Reagan, K. L. (2023). Efficacy of Oral Remdesivir Compared to GS-441524 for Treatment of Cats with Naturally Occurring Effusive Feline Infectious Peritonitis: A Blinded, Non-Inferiority Study. Viruses. https://doi.org/10.3390/v15081680

Vancouver

Cosaro E, Pires J, Castillo D, Murphy BG, Reagan KL. Efficacy of Oral Remdesivir Compared to GS-441524 for Treatment of Cats with Naturally Occurring Effusive Feline Infectious Peritonitis: A Blinded, Non-Inferiority Study. Viruses. 2023. doi:10.3390/v15081680

BibTeX
@article{Cosaro2023,
  author = {Cosaro, Emma and Pires, Jully and Castillo, Diego and Murphy, Brian G and Reagan, Krystle L},
  title = {Efficacy of Oral Remdesivir Compared to GS-441524 for Treatment of Cats with Naturally Occurring Effusive Feline Infectious Peritonitis: A Blinded, Non-Inferiority Study},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15081680}
}
Kostenlos starten →